PL322202A1 - Monthly injections as a contraceptive measure for and in substitute hormonal therapy of pre- and in-menopausal female patients - Google Patents

Monthly injections as a contraceptive measure for and in substitute hormonal therapy of pre- and in-menopausal female patients

Info

Publication number
PL322202A1
PL322202A1 PL96322202A PL32220296A PL322202A1 PL 322202 A1 PL322202 A1 PL 322202A1 PL 96322202 A PL96322202 A PL 96322202A PL 32220296 A PL32220296 A PL 32220296A PL 322202 A1 PL322202 A1 PL 322202A1
Authority
PL
Poland
Prior art keywords
substitute
hormonal therapy
female patients
menopausal female
monthly injections
Prior art date
Application number
PL96322202A
Inventor
Ursula Lachnit-Fixson
Semiramis Aydinlik
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of PL322202A1 publication Critical patent/PL322202A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL96322202A 1995-03-16 1996-03-15 Monthly injections as a contraceptive measure for and in substitute hormonal therapy of pre- and in-menopausal female patients PL322202A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19510861A DE19510861A1 (en) 1995-03-16 1995-03-16 One-month injection as a depot contraceptive and for hormone replacement therapy for peri- and premenopausal women
PCT/EP1996/001201 WO1996028165A1 (en) 1995-03-16 1996-03-15 Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women

Publications (1)

Publication Number Publication Date
PL322202A1 true PL322202A1 (en) 1998-01-19

Family

ID=7757668

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96322202A PL322202A1 (en) 1995-03-16 1996-03-15 Monthly injections as a contraceptive measure for and in substitute hormonal therapy of pre- and in-menopausal female patients

Country Status (17)

Country Link
EP (1) EP0814811A1 (en)
JP (1) JPH11501649A (en)
KR (1) KR19980703058A (en)
AR (1) AR002283A1 (en)
AU (1) AU713258B2 (en)
CA (1) CA2215382A1 (en)
CZ (1) CZ289697A3 (en)
DE (1) DE19510861A1 (en)
HU (1) HUP9801691A3 (en)
IL (1) IL117516A (en)
MX (1) MX9707009A (en)
NO (1) NO974255L (en)
NZ (1) NZ304027A (en)
PL (1) PL322202A1 (en)
SK (1) SK123997A3 (en)
WO (1) WO1996028165A1 (en)
ZA (1) ZA962177B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000313D0 (en) * 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
WO2025198399A1 (en) * 2024-03-22 2025-09-25 주식회사 에아스텍 Use of norethisterone enanthate compound for preventing or treating cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens

Also Published As

Publication number Publication date
CZ289697A3 (en) 1997-12-17
CA2215382A1 (en) 1996-09-19
JPH11501649A (en) 1999-02-09
AR002283A1 (en) 1998-03-11
NZ304027A (en) 2000-05-26
SK123997A3 (en) 1998-02-04
IL117516A0 (en) 1996-07-23
AU5110896A (en) 1996-10-02
KR19980703058A (en) 1998-09-05
AU713258B2 (en) 1999-11-25
IL117516A (en) 2000-07-26
NO974255L (en) 1997-11-14
EP0814811A1 (en) 1998-01-07
MX9707009A (en) 1997-11-29
HUP9801691A3 (en) 1999-03-01
ZA962177B (en) 1996-07-29
HUP9801691A2 (en) 1998-11-30
NO974255D0 (en) 1997-09-15
WO1996028165A1 (en) 1996-09-19
DE19510861A1 (en) 1996-09-19

Similar Documents

Publication Publication Date Title
PL341353A1 (en) Method of making tablets undergoing dispersion after being crushed in patient's teeth
PT1174135E (en) Pharmaceutical composition comprising pioglitazone and glimepiride for use in treatment of diabetes
ZA958073B (en) Method of and apparatus for administering a drug to a patient
HUP9900252A3 (en) Hormonal pharmaceutical combined preparation for contraception and kit
GB2307414B (en) Microporation of human skin for drug delivery and monitoring applications
HUP9904221A3 (en) Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia for producing pharmaceutical compositions
EP0504938A3 (en) Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient
IL112455A (en) Benzothiophene derivatives for use in combination therapy of osteoporosis together with a progestin uses thereof and pharmaceutical compositions containing them
FI971188L (en) Therapeutic vitamin-calcium combination in unit dose form in the form of a galenic tablet, method for its preparation and use
GB2256137B (en) Aromatase inhibitors for use in contraception in female primates without affecting the menstrual cycle
IL119894A (en) Use of thiazolidine in the preparation of a medicament for the treatment of osteoporosis
HUP9900186A3 (en) Use of lamellarin alkaloids in therapy and pharmaceutical compositions containing them
HUP9904027A3 (en) Use of p-aminophenol derivatives for the preparation of pharmaceutical compositions useful in the treatment of neurodegenerative diseases
ZA987723B (en) Pharmaceutical combination preparation of an inhibitor of the sodium/hydrogen exchanger and a medicament for the treatment of cardiovascular diseases
ZA984268B (en) Method and composition for administering taxanes orally to human patients
ZA966545B (en) Hormone medicaments and their use for correction of oestrogen deficiencies
GB9321341D0 (en) Therapeutic compositions for use in the treatment of skin lesions and method of making same
AP9400676A0 (en) Process for the preparation of n-methyl-3-(1-methyl-4-piperidinyl)-1h-indole-5-ethanesulphonamid-e and physiologically acceptable salts thereof
PL322202A1 (en) Monthly injections as a contraceptive measure for and in substitute hormonal therapy of pre- and in-menopausal female patients
IL127129A0 (en) Method of preparation of progesterone tablet for vaginal delivery and tablets so prepared
ZA9610584B (en) Use of rc-9 in diagnosis and treatment of proliferative arterial disease
HUP0104619A3 (en) Use of pde inhibitors in the manufacture of a medicament for the treatment of bladder diseases
GB9401745D0 (en) Improvements in and relating to the administration of medicaments or therapeutic substances
IL113183A0 (en) A method for the administration of homeopathic extracts in patients and chewing gum for use in the said method
NZ316810A (en) Alternate crystal form of tazofelone and use thereof for treating inflammation and other diseases